Press Release

CD BIOSCIENCES INTRODUCES IHC ANCILLARIES FOR ENHANCED RESEARCH AND DIAGNOSTICS



CD BioSciences is delighted to announce the addition of a new line of IHC Ancillaries to its product portfolio.

FOR IMMEDIATE RELEASE

25/03/2024

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is delighted to announce the addition of a new line of IHC Ancillaries to its product portfolio, including deparaffinators, retrievers and enzymes, washers and detergents, diluents and blockers, and mounting media. These ancillaries are developed to facilitate IHC research and diagnostics, enabling scientists, pathologists, and clinicians to achieve more accurate and reliable results.

Immunohistochemical staining depends on many different factors that can affect the staining results. Committed to advancing scientific discovery, CD BioSciences offers a wide range of reagents to ensure high quality staining and reliable, accurate results under optimal conditions each time antibodies are applied to tissue. These new IHC tools are available in component form and are easy to use. They are also supplied in a variety of sizes to meet the needs of different laboratories.

For example, the Retriever 20X with Citrate (Catalog NO: IHA040101) is designed for heat-induced epitope or nucleic acid retrieval procedures for immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), and in situ hybridization (ISH) of nucleic acids (CISH or FISH). It can be used to perform immuno or nucleic acid staining on formalin-fixed, paraffin-embedded tissue sections. This product can be utilized for any antigen or nucleic acid and promotes standardization of pretreatment procedures, resulting in more consistent and reliable results. It should be noted that this product is not intended for use in humans or animals.

Permanent Mounting Media (Catalog NO: IHA040109) is a non-toxic, biodegradable permanent mounting medium designed for the preservation of immunohistochemical and CISH stainings. It is ideal for mounting cell or tissue sections immunostained with horseradish peroxidase, alkaline phosphatase or other suitable enzymes and their substrate chromogens (e.g., DAB, HRP Black, and AP Blue). This medium is suitable for permanent mounting of cell or tissue samples treated with substrate-chromogen protectors to preserve solvent-sensitive substrate-chromogen stains such as AEC, Fast Red, HRP Blue, HRP Green, Alk Magenta, Alk Scarlet, Alk Red, and Alk Brown.

CD BioSciences offers Background Blocker (Catalog NO: IHA040302) to block or reduce antibody or antigen/nucleic acid-associated backgrounds that produce high backgrounds during IHC, CISH/FISH staining procedures. The reagent minimizes non-specific interactions that may be induced by antibodies or nucleic acids and promotes specific antigen-antibody binding. It can also be used as a diluent for different types of monoclonal, polyclonal, and control antibodies that produce a high background during IHC or CISH/FISH staining procedures.

CD BioSciences offers a series of ancillaries to help researchers and diagnosticians improve the efficiency and accuracy of their IHC assays, empowering scientists to unlock deeper insights into cellular processes and disease mechanisms. To learn more about the new products, please visit https://www.bioimagingtech.com/ihc-ancillaries.html.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.

Tags:
IHC Ancillaries  |  CD BioSciences  |  

---

Organisation Profile:






Press release contact details for

Name
Tel
Fax
Email
Website
Organisation
Address
Town
County0
Postcode




Other press releases from

STEMart Introduces Bioburden Tissue Testing Services for Medical Devices
STEMart Launches Limulus Amebocyte Lysate Tests for Medical Devices
STEMart Launches Bioburden and Sterility Testing for Medical Devices
STEMart Announces Medical Device Reprocessing Validation Services
STEMart Launches Disinfection Validation Services for Reusable Medical Devices
STEMart Announces New Particulate Matter Testing Services
STEMart Launches Ethylene Oxide Sterilant Residual Testing Services to Ensure Medical Device Safety
STEMart Launches New Radiation Quarterly Dose Audit Services for Medical Devices
STEMart Announces Rapid Endotoxin Testing Services for Medical Devices
STEMart Launches Disinfection Efficacy Studies Services for Medical Devices
STEMart Announces Comprehensive Filter Testing Services for Pharmaceutical and Medical Device Manufacturers
STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety
STEMart Announces Comprehensive Development Services for the Medical Device Industry
STEMart Revolutionizes Medical Device Development with Comprehensive Prototyping Services
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
STEMart Announces Pilot Production Services for Medical Devices
STEMart Launches Comprehensive Medical Device Packaging Solutions
STEMart Announces Sterile Barrier & Seal Integrity Testing for Medical Device Packaging
STEMart Announces Transportation and Distribution Simulation Services for Medical Device Manufacturers

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.